Pro Medicus Limited (AU:PME) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pro Medicus Limited reports a record-breaking full-year with a 29% increase in revenue to $161.5 million and a 36.5% rise in net profit to $82.8 million, driven by significant growth in North America which now represents 90% of total revenue. The company’s transaction-based model and new contract wins, such as the $140M deal with Baylor Scott & White, suggest a strong growth trajectory and a sustainable high-margin business. With only 7% of the US market captured, the company sees potential for continued expansion in a broad range of healthcare segments.
For further insights into AU:PME stock, check out TipRanks’ Stock Analysis page.